Delivery Order SPE2DR25D3004-SPE2DR26FXLT5
Award Date 11/13/25
Potential Completion Date 11/14/25
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,715.74 for TALTZ 80 MG/ML AutoInjector on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication commonly prescribed for...
- The Defense Logistics Agency awarded a delivery order valued at $6,641.24 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis,...
- The Defense Logistics Agency awarded a $23,185.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML AutoInjector on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and...
- The Defense Logistics Agency awarded a $7,021.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML autoinjector on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing...
- The Defense Logistics Agency awarded a delivery order valued at $4,980.90 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed price delivery order, issued without set-aside designation, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication primarily used to treat autoimmune and inflammatory conditions including...
- The Defense Logistics Agency awarded a $26,229.86 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injectors, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication used to treat inflammatory...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,831.00 for TALTZ 80 mg/ml autoinjector on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order is not set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication commonly prescribed for autoimmune conditions including psoriasis, psoriatic arthritis,...
- The Defense Logistics Agency awarded a delivery order valued at $3,499.42 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $14,341.09 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL Autoinjector on November 13, 2025, with a completion date of November 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions including psoriasis and rheumatoid...
- The Defense Logistics Agency awarded a delivery order valued at $6,998.84 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant commonly prescribed for autoimmune conditions...